CIBC World Market
NBIX icon

CIBC World Market’s Neurocrine Biosciences NBIX Stock Holding History

CIBC World Market’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Buy
+3,258
New +$483K ﹤0.01% 1195
2023
Q1 		– Sell
-15,205
Closed -$1.82M – 1311
2022
Q4 		$1.82M Buy
+15,205
New +$1.78M 0.01% 608
2018
Q3 		– Sell
-10,481
Closed -$1.03M – 1195
2018
Q2 		$1.03M Buy
+10,481
New +$938K ﹤0.01% 656

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC World Market's NBIX Position: Q2 2026 in Review

CIBC World Market opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 3,258 shares worth $549K. The stake represents ﹤0.01% of the portfolio and ranks #1195 among its holdings. This is a return to the name: CIBC World Market previously reported a position in NBIX as recently as Q4 2022.

CIBC World Market first reported a position in NBIX in Q2 2018 and has held it in 3 quarters since. The position peaked at $1.82M in Q4 2022. 778 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • CIBC World Market held 3,258 shares of Neurocrine Biosciences worth $549K as of Q2 2026.
  • Neurocrine Biosciences was a new CIBC World Market position in Q2 2026.
  • Neurocrine Biosciences made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1195 holding.
  • CIBC World Market first reported a position in Neurocrine Biosciences in Q2 2018 and has held it in 3 quarters since.
  • CIBC World Market's Neurocrine Biosciences position peaked at $1.82M in Q4 2022.
  • 778 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.